Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report)’s share price gapped down before the market opened on Monday . The stock had previously closed at $1.52, but opened at $1.42. Akso Health Group shares last traded at $1.54, with a volume of 787 shares changing hands.
Wall Street Analyst Weigh In
AHG has been the subject of a number of research analyst reports. Wall Street Zen upgraded shares of Akso Health Group to a “sell” rating in a research note on Saturday, May 2nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Akso Health Group in a research note on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.
Read Our Latest Stock Report on Akso Health Group
Akso Health Group Trading Down 1.5%
Institutional Investors Weigh In On Akso Health Group
A hedge fund recently bought a new position in Akso Health Group stock. SmartHarvest Portfolios LLC acquired a new stake in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 16,748 shares of the company’s stock, valued at approximately $27,000. 1.21% of the stock is currently owned by hedge funds and other institutional investors.
Akso Health Group Company Profile
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Further Reading
- Five stocks we like better than Akso Health Group
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
- Why Micron Is Doubling Down While the HBM Shortage Persists
- China’s Helium Ban Could Reshape the AI Supply Chain
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
